Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières.
Saved in:
Main Authors: | Jean-Paul Guthmann, Francesco Checchi, Ingrid van den Broek, Suna Balkan, Michel van Herp, Eric Comte, Oscar Bernal, Jean-Marie Kindermans, Sarah Venis, Dominique Legros, Philippe J Guerin |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/a5092d86b19441e9a731a11dae685d0d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience.
by: Vincent Brown, et al.
Published: (2008) -
Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Médecins Sans Frontières.
by: Doris Schopper, et al.
Published: (2009) -
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
by: Freek de Haan, et al.
Published: (2021) - Médecine
-
High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli.
by: Hiroko Tsuruta, et al.
Published: (2009)